Tidepool Loop App for Automating Insulin Dosing Now with FDA
Written by Mike Hoskins and Amy Tenderich on February 1, 2021 — Fact checked by Jennifer Chesak
Courtesy of Tidepool
Tidepool Loop, a first-of-its-kind app that will connect with a variety of compatible insulin pumps and continuous glucose monitors (CGMs) to automate insulin dosing, has been submitted for FDA approval.
This is big, Diabetes Friends, because new automated insulin delivery (AID) systems are the future of diabetes care, and because the Tidepool Loop project represents over two years of development work aimed at bringing do-it-yourself (DIY) “artificial pancreas” innovation into an official, FDA-regulated product that will be broadly available via the iOS app store.